XML 40 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (2,951,649) $ (3,334,480)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 22,803 33,459
Stock-based compensation 426,809 1,205,430
Changes in assets and liabilities:    
Royalty receivables (354,465) (275,800)
Prepaid expenses and other assets 47,526 127,014
Deferred revenue (8,750) 38,749
Accounts payable and accrued expenses 120,272 (25,986)
Net cash used in operating activities (2,697,454) (2,231,614)
Cash flows from investing activities:    
Purchase of fixed assets (109,817) (44,539)
Change in short term investments (3,003,915) (6,535)
Net cash used in investing activities (3,113,732) (51,074)
Cash flows from financing activities:    
Proceeds from sale of common stock 3,278,250   
Net proceeds from exercise of options and warrants 304,788   
Net cash provided by financing activities 3,583,038   
Net decrease in cash and cash equivalents (2,228,148) (2,282,688)
Cash and cash equivalents at beginning of year 5,866,123 8,390,233
Cash and cash equivalents at end of period $ 3,637,975 $ 6,107,545